Luis Gutiérrez-Rojas

TL;DR: Concerns remain regarding an effective protocol to maintain the clinical antidepressant effect of ketamine seen with acute administration and the safety of ketamines and esketamine in the long term, specifically related to potential neurocognitive and urologic toxicity, together with the potential induction of substance use disorders.

TL;DR: To identify risk factors associated with suicide of patients with schizophrenia and provide clinical recommendations, which integrate research findings into a consensus based on clinical experience and evidence.

TL;DR: There are remarkable interregional differences in the disorder's prevalence, as well as in certain sociodemographic correlates.

TL;DR: Among the BD patients, who experience lower physical and mental QoL even in a euthymic period, the optimal control of depressive symptoms as well as the availability of social support may enhance their well-being.

TL;DR: An updated review of the available literature on weight gain and increase of body mass index (BMI) among children and adolescents treated with antipsychotic medications found that second-generation antipsychotics (SGAs) are associated with a greater risk for antipipsychotic-induced weight gain although this oversimplification should be clarified.